Trial Profile
Prospective Randomised Clinical Study on Pharmacogenetics of Gonadotropin Receptors in Relation to Pregnancy and Life Birth Rate as Well as Unwanted Side Effects Such as Ovarian Hyper Stimulation Syndrome During Assisted Reproduction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Apr 2022
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary) ; Menotropin (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms HEART
- 21 Apr 2022 Status changed from recruiting to completed.
- 21 Jan 2020 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
- 21 Jan 2020 Planned primary completion date changed from 30 Jun 2020 to 30 Jun 2021.